Tri Locum Partners »

Boston Scientific Corporation shares owned by Tri Locum Partners

Quarter-by-quarter ownership of Boston Scientific Corporation (BSX) shares owned by Tri Locum Partners from 13F filings

Historical chart of Tri Locum Partners investment in Boston Scientific Corporation

Tip: Access up to 7 years of quarterly data

All positions including Boston Scientific Corporation held by Tri Locum Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boston Scientific Corporation by Tri Locum Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $50M 521k 95.35

More positions owned by Tri Locum Partners

Johnson & Johnson (JNJ)
Danaher Corporation (DHR)
Eli Lilly & Co. (LLY)
United Therapeutics Corporation (UTHR)
Ascendis Pharma A/s Sponsored Adr (ASND)
Madrigal Pharmaceuticals (MDGL)
Boston Scientific Corporation (BSX)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Ionis Pharmaceuticals (IONS)
Vera Therapeutics Cl A (VERA)
Axsome Therapeutics (AXSM)
Argenx Se Sponsored Adr (ARGX)
Nuvalent Inc-a (NUVL)
Dex (DXCM)
Dianthus Therapeutics (DNTH)

View all positions for Tri Locum Partners

Top funds holding Boston Scientific Corporation

Vanguard Group
BlackRock
FMR
State Street Corporation
Geode Capital Management
PRIMECAP Management Company
Jpmorgan Chase & Co
Capital World Investors
Norges Bank Investment Management
Bollard
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Goldman Sachs Group
UBS Group
Wellington Management Company
Northern Trust

View all funds holding Boston Scientific Corporation